KOL KnockoutTM: Menopause Edition — A Targeted Approach to t -

Name: KOL Knockout™: Menopause Edition — A Targeted Approach to the Treatment of Menopausal Vasomotor Symptoms
Uploaded: 2023-08-14T04:00:00+00:00
Duration: 1 h 18 min 31 s
Description: This popular CME program is a fun and exciting game show-style quiz competition that features key opinion leaders (KOLs) as contestants. Hosted by Program

Media formats available:

Details

Presenters

Overview
This popular CME program is a fun and exciting game show-style quiz competition that features key opinion leaders (KOLs) as contestants. Hosted by Program Chair Dr. Risa Kagan, the program features Drs. Jewel Kling, Nanette Santoro, and Chrisandra Shufelt as contestants. Dr. Kagan presents cases of patients with menopausal vasomotor symptoms and the KOLs weigh in on their preferred treatment option. Watch to find out who won!
This content was captured during a live-virtual symposium. Voting took place during the symposium.

This activity is supported by an independent educational grant from Astellas and in-kind support from the American College of Osteopathic Obstetricians and Gynecologists (ACOOG).
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Explain the role of sex hormones in thermoregulation and the relationship with the symptomology of VMS during the menopause transition
- Identify women with suboptimally managed VMS, and create a care plan based on the demonstrated evidence of efficacy and safety along with cautions with treatment selection for appropriate and timely symptom management
- Create a strategy to communicate and educate patients about their VMS to achieve a physician-patient partnership for treatment selection and outcomes that align with patient goals
Accreditation
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Evolve is approved by the California Board of Registered Nursing, Provider Number 17004, for 1.5 contact hours.
Participation Method
In order to obtain credit, proceed through the program, complete the posttest, evaluation and submit for credit.
Faculty and Disclosures
Risa Kagan, MD, FACOG, CCD, NCMP
Clinical Professor, Dept of Obstetrics and Gynecology & Reproductive Sciences, UCSF
Gynecologist and Clinical Research
Sutter East Bay Medical Foundation
Berkeley, CA

Juliana (Jewel) Kling, MD, MPH, NCMP, FACP, IF
Professor of Medicine
Chair, Women’s Health Internal Medicine
Suzanne Hanson Poole Dean, Mayo Clinic Alix School of Medicine
Scottsdale, AZ

Nanette F. Santoro, MD
Professor and E. Stewart Taylor Chair
Divisions of Reproductive Endocrinology and Infertility & Reproductive Sciences
Department of Obstetrics and Gynecology
University of Colorado Anschutz
Aurora, CO

Chrisandra Shufelt, MD, MS, FACP, NCMP
Chair, Division of General Internal Medicine
Associate Director, Women’s Health Research Center
Mayo Clinic
Jacksonville, FL

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Risa Kagan, MD, FACOG, CCD, NCMP, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Amgen, Astellas, Avion, Carrot Fertility, Lisa Health, Pfizer, Pharmavite, Scynexis, and Therapeutics MD. Speaker's Bureau: Astellas and Pfizer.
Juliana (Jewel) Kling, MD, MPH, NCMP, FACP, IF, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Everyday Health, Kindra & Procter and Gamble Ventures, and Triangle Insights Group. Speaker's Bureau: Medscape (WebMD).
Nanette F. Santoro, MD, has had a financial relationship or afficliation with the following ineligible companies in the form of Consultant: Ansh Labs and FertilityIQ. Medical Advisory Board: Astellas Pharma, Menogenix Inc, Project Ember/Amazon, and Que Oncology.
Chrisandra Shufelt, MD, MS, FACP, NCMP, has had a financial relationship or affiliation with the following ineligible companies in the form of Grant/Research Support: National Institutes of Health (NIH R01).
The Evolve staff and planners have no financial relationships with ineligible companies.
Elizabeth Whinston, MD, PhD, peer reviewer, has no financial relationships with ineligible companies.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Astellas, or the American College of Osteopathic Obstetricians and Gynecologists (ACOOG).
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date: 08/14/2023
Expiration Date: 08/14/2024